4D Molecular Therapeutics (FDMT) Earnings Date & Reports

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FDMT is expected to report earnings to fall 15.48% to -72 cents per share on August 07

4D Molecular Therapeutics FDMT Stock Earnings Reports

Q2'25

Est.

$-0.73

Q1'25

Est.

$-0.86

Q4'24

Missed

by $0.05

Q3'24

Missed

by $0.11

Q2'24

Beat

by $0.05

The last earnings report on May 08 showed earnings per share of -86 cents, meeting the estimate of -86 cents. With 1.44M shares outstanding, the current market capitalization sits at 177.89M.

View a ticker or compare two or three

Compare

FDMT